Parmida Sadat Pezeshki

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Hodgkin Lymphoma

Coronavirus Disease

Top Venues

Expert opinion on investigational drugs

Expert opinion on biological therapy

Expert review of clinical immunology

Expert review of anticancer therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ava Aghakhani, Parmida Sadat Pezeshki, Nima Rezaei
The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy. Expert opinion on investigational drugs (2024)
Ava Aghakhani, Parmida Sadat Pezeshki, Nima Rezaei
The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy. Expert opinion on investigational drugs (2024)
Ava Aghakhani, Parmida Sadat Pezeshki, Nima Rezaei
The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy. Expert opinion on investigational drugs 33 (7) (2024)
Pooria Ahmadi, Arian Afzalian, Arash Jalali, Saeed Sadeghian, Farzad Masoudkabir, Alireza Oraii, Aryan Ayati, Sepehr Nayebirad, Parmida Sadat Pezeshki, Masoumeh Lotfi Tokaldani, Akbar Shafiee, Mohammad Mohammadi, Elham Sanei, Masih Tajdini, Kaveh Hosseini
Age and gender differences of basic electrocardiographic values and abnormalities in the general adult population; Tehran Cohort Study. BMC cardiovascular disorders 23 (1) (2023)
Seyed Majid Mousavi Movahed, Hamed Akhavizadegan, Fatemeh Dolatkhani, Samaneh Akbarpour, Seyed Aria Nejadghaderi, Morvarid Najafi, Parmida Sadat Pezeshki, Akram Khalili Noushabadi, Hoomaan Ghasemi
Incidence of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without antiviral medications: A retrospective study. PloS one 18 (10) (2023)
Mohammad Erfan Lotfi, Parmida Sadat Pezeshki, Nima Rezaei
The role of interleukins in pathogenesis and prognosis of atrial fibrillation. Expert review of clinical immunology (2023)
Parniyan Sadeghi, Parmida Sadat Pezeshki, Nima Rezaei
Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders. European journal of pediatrics (2023)
Parmida Sadat Pezeshki, Nima Rezaei
Immune checkpoint inhibition in COVID-19: risks and benefits. Expert opinion on biological therapy 21 (9) (2021)
Parmida Sadat Pezeshki, Aysan Moeinafshar, Faezeh Ghaemdoust, Sepideh Razi, Mahsa Keshavarz-Fathi, Nima Rezaei
Advances in pharmacotherapy for neuroblastoma. Expert opinion on pharmacotherapy 22 (17) (2021)
Parmida Sadat Pezeshki, Pouya Mahdavi Sharif, Nima Rezaei
Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors. Expert opinion on biological therapy 21 (12) (2021)
Parmida Sadat Pezeshki, Mahsa Eskian, Michael R Hamblin, Nima Rezaei
Immune checkpoint inhibition in classical hodgkin lymphoma. Expert review of anticancer therapy 21 (9) (2021)